Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy

A major goal in diseases is identifying a potential therapeutic agent that is cost-effective and can remedy some, if not all, disease symptoms. In Alzheimer’s disease (AD), aggregation of hyperphosphorylated tau protein is one of the neuropathological hallmarks, and Tau pathology correlates better w...

Full description

Bibliographic Details
Main Authors: Tariq Ahmed, Ann Van der Jeugd, Raphaëlle Caillierez, Luc Buée, David Blum, Rudi D’Hooge, Detlef Balschun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2020.570223/full
_version_ 1819228863441403904
author Tariq Ahmed
Tariq Ahmed
Ann Van der Jeugd
Ann Van der Jeugd
Raphaëlle Caillierez
Raphaëlle Caillierez
Luc Buée
Luc Buée
David Blum
David Blum
Rudi D’Hooge
Rudi D’Hooge
Detlef Balschun
Detlef Balschun
author_facet Tariq Ahmed
Tariq Ahmed
Ann Van der Jeugd
Ann Van der Jeugd
Raphaëlle Caillierez
Raphaëlle Caillierez
Luc Buée
Luc Buée
David Blum
David Blum
Rudi D’Hooge
Rudi D’Hooge
Detlef Balschun
Detlef Balschun
author_sort Tariq Ahmed
collection DOAJ
description A major goal in diseases is identifying a potential therapeutic agent that is cost-effective and can remedy some, if not all, disease symptoms. In Alzheimer’s disease (AD), aggregation of hyperphosphorylated tau protein is one of the neuropathological hallmarks, and Tau pathology correlates better with cognitive impairments in AD patients than amyloid-β load, supporting a key role of tau-related mechanisms. Selenium is a non-metallic trace element that is incorporated in the brain into selenoproteins. Chronic treatment with sodium selenate, a non-toxic selenium compound, was recently reported to rescue behavioral phenotypes in tau mouse models. Here, we focused on the effects of chronic selenate application on synaptic transmission and synaptic plasticity in THY-Tau22 mice, a transgenic animal model of tauopathies. Three months with a supplement of sodium selenate in the drinking water (12 μg/ml) restored not only impaired neurocognitive functions but also rescued long-term depression (LTD), a major form of synaptic plasticity. Furthermore, selenate reduced the inactive demethylated catalytic subunit of protein phosphatase 2A (PP2A) in THY-Tau22 without affecting total PP2A.Our study provides evidence that chronic dietary selenate rescues functional synaptic deficits of tauopathy and identifies activation of PP2A as the putative mechanism.
first_indexed 2024-12-23T11:04:02Z
format Article
id doaj.art-92bf986f882a49b0ac67f35e58e84c5e
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-12-23T11:04:02Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-92bf986f882a49b0ac67f35e58e84c5e2022-12-21T17:49:32ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992020-10-011310.3389/fnmol.2020.570223570223Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of TauopathyTariq Ahmed0Tariq Ahmed1Ann Van der Jeugd2Ann Van der Jeugd3Raphaëlle Caillierez4Raphaëlle Caillierez5Luc Buée6Luc Buée7David Blum8David Blum9Rudi D’Hooge10Rudi D’Hooge11Detlef Balschun12Detlef Balschun13Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, BelgiumLeuven Brain Institute, Leuven, BelgiumLeuven Brain Institute, Leuven, BelgiumLaboratory of Biological Psychology, Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, BelgiumUniv. Lille, Inserm, CHU Lille, U1172—LilNCog—Lille Neuroscience and Cognition, Lille, FranceAlzheimer and Tauopathies, LabEx DISTALZ, Lille, FranceUniv. Lille, Inserm, CHU Lille, U1172—LilNCog—Lille Neuroscience and Cognition, Lille, FranceAlzheimer and Tauopathies, LabEx DISTALZ, Lille, FranceUniv. Lille, Inserm, CHU Lille, U1172—LilNCog—Lille Neuroscience and Cognition, Lille, FranceAlzheimer and Tauopathies, LabEx DISTALZ, Lille, FranceLeuven Brain Institute, Leuven, BelgiumLaboratory of Biological Psychology, Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, BelgiumBrain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, BelgiumLeuven Brain Institute, Leuven, BelgiumA major goal in diseases is identifying a potential therapeutic agent that is cost-effective and can remedy some, if not all, disease symptoms. In Alzheimer’s disease (AD), aggregation of hyperphosphorylated tau protein is one of the neuropathological hallmarks, and Tau pathology correlates better with cognitive impairments in AD patients than amyloid-β load, supporting a key role of tau-related mechanisms. Selenium is a non-metallic trace element that is incorporated in the brain into selenoproteins. Chronic treatment with sodium selenate, a non-toxic selenium compound, was recently reported to rescue behavioral phenotypes in tau mouse models. Here, we focused on the effects of chronic selenate application on synaptic transmission and synaptic plasticity in THY-Tau22 mice, a transgenic animal model of tauopathies. Three months with a supplement of sodium selenate in the drinking water (12 μg/ml) restored not only impaired neurocognitive functions but also rescued long-term depression (LTD), a major form of synaptic plasticity. Furthermore, selenate reduced the inactive demethylated catalytic subunit of protein phosphatase 2A (PP2A) in THY-Tau22 without affecting total PP2A.Our study provides evidence that chronic dietary selenate rescues functional synaptic deficits of tauopathy and identifies activation of PP2A as the putative mechanism.https://www.frontiersin.org/article/10.3389/fnmol.2020.570223/fullAlzheimer’s diseasechronic oral treatmentsynaptic transmissionsynaptic plasticitylong-term depressionneurocognitive functions
spellingShingle Tariq Ahmed
Tariq Ahmed
Ann Van der Jeugd
Ann Van der Jeugd
Raphaëlle Caillierez
Raphaëlle Caillierez
Luc Buée
Luc Buée
David Blum
David Blum
Rudi D’Hooge
Rudi D’Hooge
Detlef Balschun
Detlef Balschun
Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
Frontiers in Molecular Neuroscience
Alzheimer’s disease
chronic oral treatment
synaptic transmission
synaptic plasticity
long-term depression
neurocognitive functions
title Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
title_full Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
title_fullStr Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
title_full_unstemmed Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
title_short Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy
title_sort chronic sodium selenate treatment restores deficits in cognition and synaptic plasticity in a murine model of tauopathy
topic Alzheimer’s disease
chronic oral treatment
synaptic transmission
synaptic plasticity
long-term depression
neurocognitive functions
url https://www.frontiersin.org/article/10.3389/fnmol.2020.570223/full
work_keys_str_mv AT tariqahmed chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT tariqahmed chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT annvanderjeugd chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT annvanderjeugd chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT raphaellecaillierez chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT raphaellecaillierez chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT lucbuee chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT lucbuee chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT davidblum chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT davidblum chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT rudidhooge chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT rudidhooge chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT detlefbalschun chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy
AT detlefbalschun chronicsodiumselenatetreatmentrestoresdeficitsincognitionandsynapticplasticityinamurinemodeloftauopathy